R. Prasad

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

G.P. Boland, Izzah Butt, R. Prasad et al. · British Journal of Cancer · 2004 · 198 citations · Full text

Medicine, Cancer Biology, Oncology +14

Short‐term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma

R. Prasad, G.P. Boland, Angela Cramer et al. · Cancer · 2003 · 28 citations · Full text

Medicine, Oncology, Breast Oncology +13

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

M.A. Bergamino, Elena López‐Knowles, Gabriele Morani et al. · EBioMedicine · 2022 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15

Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast

G.P. Boland, Adam McKeown, Kai Chio Chan et al. · British Journal of Cancer · 2003 · 16 citations · Full text

Medicine, Oncology, Surgery +17